$ATMP Cashflow Statement | Understand Stock

$ATMP

$36.08 +$0.12 (0.33%) Close

$ATMP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated cash flow statement

In millions of GBP, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from (used in) operating activities
Reconciliation of profit before tax to net cash flows from operating activities:
Profit before tax
Adjustment for non-cash items:
Credit impairment charges
Depreciation, amortisation and impairment of property, plant, equipment and intangibles
Provisions and pension charges
Net loss on disposal of investments and property, plant and equipment
Other non-cash movements including exchange rate movements
Changes in operating assets and liabilities
Net decrease in cash collateral and settlement balances
Net decrease/ (increase) in loans and advances at amortised cost
Net (increase)/decrease in loans and advances at amortised cost
Net increase in reverse repurchase agreements and other similar secured lending
Net (decrease)/increase in debt securities in issue
Net increase in deposits at amortised cost
Net increase/(decrease) in debt securities in issue
Net (decrease)/increase in repurchase agreements and other similar secured borrowing
Net decrease/(increase) in derivative financial instruments
Net (increase)/decrease in trading portfolio assets
Net increase/(decrease) in trading portfolio liabilities
Net increase/(decrease) in financial assets and liabilities at fair value through the income statement
Net increase in other assets
Net decrease in other liabilities
Corporate income tax paid
Net cash from operating activities
Cash flows from (used in) investing activities
Purchase of debt securities at amortised cost
Proceeds from redemption or sale of debt securities at amortised cost
Purchase of financial assets at fair value through other comprehensive income
Proceeds from sale or redemption of financial assets at fair value through other comprehensive income
Purchase of property, plant and equipment and investment in intangibles
Disposal of subsidiaries and associates, net of cash disposed
Acquisition of business
Other cash flows associated with investing activities
Net cash from investing activities
Cash flows from (used in) financing activities
Dividends paid and other coupon payments on equity instruments
Issuance of subordinated liabilities
Redemption of subordinated liabilities
Issue of shares and other equity instruments
Repurchase of shares and other equity instruments
Capital contribution
Vesting of employee share schemes
Net cash from financing activities
Effect of exchange rates on cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Cash and cash equivalents comprise:
Cash and balances at central banks
Loans and advances to banks with original maturity of three months or less
Cash collateral balances with central banks with original maturity less than three months
Cash collateral balances with central banks with original maturity of three months or less
Treasury and other eligible bills with original maturity of three months or less

Comments